Patents by Inventor Sandro Giuliani

Sandro Giuliani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9101627
    Abstract: Disclosed are pharmaceutical compositions containing, as the active ingredients, a mixture of a hyaluronic acid polymer with a bradykinin B2 receptor antagonist. Said compositions have proved especially effective in the treatment of degenerative joint diseases such as osteoarthritis using intra-articular injections.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: August 11, 2015
    Assignee: ISTITUTO LUSO FARMACO D'ITALIA S.P.A.
    Inventors: Carlo Alberto Maggi, Sandro Giuliani, Laura Quartara
  • Patent number: 8476276
    Abstract: Disclosed are pharmaceutical compositions containing, as active ingredients, a mixture of a corticosteroid and a kinin B2 receptor antagonist. Said compositions have proved particularly effective, especially in the treatment of inflammatory disorders such as asthma, ophthalmic or dermatological disorders and, above all, as regards the joints, arthritis.
    Type: Grant
    Filed: July 3, 2009
    Date of Patent: July 2, 2013
    Assignee: Istituto Luso Farmaco d'Italia S.p.A.
    Inventors: Sandro Giuliani, Carlo Alberto Maggi
  • Publication number: 20130131128
    Abstract: The present invention relates to an association of active principles, i.e. of a xanthine oxidase inhibitor with one or more angiotensin II receptor antagonists, pharmaceutical compositions comprising said active principles, for use in a therapeutic treatment in humans or animals, and methods for the preparation thereof.
    Type: Application
    Filed: May 9, 2011
    Publication date: May 23, 2013
    Applicant: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
    Inventors: Francesco Melani, Sandro Giuliani, Carlo Alberto Maggi
  • Publication number: 20130116291
    Abstract: The present invention relates to the association of active principles, i.e. of a xanthine oxidase inhibitor with one or more HMG CoA reductase inhibitors, pharmaceutical compositions comprising said active principles, for use in a human or veterinary therapeutic treatment, and methods for the preparation thereof.
    Type: Application
    Filed: May 6, 2011
    Publication date: May 9, 2013
    Applicant: Menarini International Operations Luxembourg S.A.
    Inventors: Francesco Melani, Sandro Giuliani, Carlo Alberto Maggi
  • Publication number: 20110112011
    Abstract: Disclosed are pharmaceutical compositions containing, as active ingredients, a mixture of a corticosteroid and a kinin B2 receptor antagonist. Said compositions have proved particularly effective, especially in the treatment of inflammatory disorders such as asthma, ophthalmic or dermatological disorders and, above all, as regards the joints, arthritis.
    Type: Application
    Filed: July 3, 2009
    Publication date: May 12, 2011
    Applicant: ISTITUTO LUSO FARMACO D'ITALIA S.P.A.
    Inventors: Sandro Giuliani, Carlo Alberto Maggi
  • Publication number: 20100292156
    Abstract: Disclosed are pharmaceutical compositions containing, as the active ingredients, a mixture of a hyaluronic acid polymer with a bradykinin B2 receptor antagonist. Said compositions have proved especially effective in the treatment of degenerative joint diseases such as osteoarthritis using intra-articular injections.
    Type: Application
    Filed: November 10, 2008
    Publication date: November 18, 2010
    Applicant: ISTITUTO LUSO FARMACO D'ITALIA S.P.A.
    Inventors: Carlo Alberto Maggi, Sandro Giuliani, Laura Quartara
  • Publication number: 20080004283
    Abstract: There are disclosed pharmaceutical compositions for topical administration or for use in mesotherapy, containing a PDE3 inhibitor as active ingredient, and their use in the treatment of cellulite.
    Type: Application
    Filed: December 6, 2005
    Publication date: January 3, 2008
    Applicant: MENARINI RICERCHE S.P.A.
    Inventors: Massimiliana Landini, Sandro Giuliani, Alessandro Giolitti
  • Patent number: 7015196
    Abstract: Basic monocyclic compounds having general formula (I) useful as NK-2 antagonists are described, processes for their preparation and pharmaceutical compositions containing them are also described.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: March 21, 2006
    Assignee: Menarini Ricerche S.p.A.
    Inventors: Enzo Perrotta, Danilo Giannotti, Maria Altamura, Sandro Giuliani, Carlo Alberto Maggi
  • Patent number: 5128447
    Abstract: A synthetic peptide corresponding to the following formula:X--Asp--Y--DTrp--Val--DTrp--Z--K--NH.sub.2where:X=H, Arg, DArg, Lys, DLys, Thr, DThrY=Tyr, Trp, DTrp, Ser, MetZ=Trp, DTrpK=Arg, Phe, DTrp, Tyr, Metand pharmaceutically acceptable salts thereof with organic and inorganic acids as competitive antagonists against neurokinin A (NK-2 receptor).
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: July 7, 1992
    Assignee: A. Menarini Industrie Farmaceutiche Riunite S.r.l.
    Inventors: Paolo Rovero, Vittorio Pestellini, Carlo A. Maggi, Riccardo Patacchini, Paolo Santicioli, Sandro Giuliani, Alberto Meli